HopeStage
Back to all studies
CompletedNCT04015869

Allopregnanolone for Stress-Related Craving and Anxiety

About this titleRead the official source — NCT04015869
Medication studyAges 21–50United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 50 years.

Listed locations
West HavenSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 1, 2019
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 50 Years
Official registry ID
NCT04015869
Official title
Show the full official title

Effect of Allopregnanolone on Stress-induced Craving

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

West Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including Allopregnanolone and Placebos.

Who was this study for?

Listed age limits: 21 years to 50 years.

Want to explore more studies?

Explore studies